Clinical Trial Update: The Impact on Therapeutic Effect and Tolerance of Treatment for Patients With Hepatocellular Carcinoma in Transcatheter Arterial Chemoembolization (TACE) of Dexamethasone Application: A Random, Double-blind, Controlled, Clinical Trial. [Phase 3]

View source ↗

Summary

This Phase 3 randomized, double-blind trial evaluates the added use of dexamethasone during transcatheter arterial chemoembolization for hepatocellular carcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Sun Yat-sen University | Conditions: HepatoCellular Carcinoma | Phase 3 | Status: UNKNOWN